Class III
Ongoing
Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.
This recall is currently active, issued January 22, 2025. It was issued by Akron Pharma, Inc..
- Company
- Akron Pharma, Inc.
- Recall Initiated
- December 12, 2024
- Posted
- January 22, 2025
- Recall Number
- D-0198-2025
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 456 bottles
- Firm Location
- Fairfield, NJ, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Distribution
Nationwide in the US
Lot / Code Info
Lot: KDC0124002B Exp 09/30/2026
More recalls by Akron Pharma, Inc.
OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL...
Oct 30, 2024 · Class II
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026